Expression of cytochromes P450 in human breast tissue and tumors

Drug Metabolism and Disposition

Volumn 24, Issue 8, 1996, Pages 899-905

  Huang, Zeqi ^a   Fasco, Michael J ^a,b   Figge, Helen L ^c   Keyomarsi, Khandan ^b   Kaminsky, Laurence S ^a,b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b WADSWORTH CENTER   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CYTOCHROME P450; MESSENGER RNA; XENOBIOTIC AGENT;

ARTICLE; BREAST TUMOR; CONTROLLED STUDY; DRUG METABOLISM; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOUTHERN BLOTTING; XENOBIOTIC METABOLISM;

BREAST; BREAST NEOPLASMS; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; RNA, MESSENGER;

EID: 0029834242     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. F. P. Guengerich: Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 4, 391-407 (1991).
2. K. Kawajiri and Y. Fujii-Kuriyama: P450 and human cancer. Jpn. J. Cancer Res. 82, 1325-1335 (1991).
3. F. P. Guengerich: Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res. 48, 2946-2954 (1988).
4. F. J. Gonzalez: Cytochrome P450 in humans. In "Cytochrome P450" (J. B. Schenkman and H. Greim, eds.), pp. 239-257. Springer-Verlag, Berlin, 1993.
5. T. R. Sutter, Y. M. Tang, C. L. Hayes, Y.-Y.P. Wo, E. W. Jabs, X. Li, H. Yin, H. C. W. Cody, and W. F. Greenlee: Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem. 269, 13092-13099 (1994).
6. F. J. Gonzalez: Human cytochromes P450: problems and prospects. Trends Pharmacol. Sci. 13, 346-352 (1992).
7. M. Unger, H. Kiaer, M. Blichert-Toft, J. Olsen, and J. Clausen: Organochlorine compounds in human breast fat from deceased without breast cancer and in a biopsy material from newly diagnosed patients undergoing breast surgery. Environ. Res. 34, 24-28 (1984).
8. M. Wasserman, D. P. Noguekira, L. Tomatis, A. P. Mirra, H. Shibata, G. Arie, S. Cucos, and D. Wasserman: Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull Environ. Contam. Toxicol. 15, 478-484 (1976).
9. F. Falck, A. Ricci, M. Wolff, J. Godbold, and P. Deckers: Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch. Environ. Health 47, 143-146 (1992).
10. M. S. Wolff, P. G. Toniolo, E. W. Lee, M. Rivera, and N. Dubin: Blood levels of organochlorine residues and risk of breast cancer. J. Ntl. Cancer Inst. 85, 648-652 (1993).
11. T. Price, J. Aitken, J. Head, M. Mahendroo, G. Means, and E. Simpson: Determination of aromatase cytochrome P450 messenger ribonucleic acid in human breast tissue by competitive polymerase chain reaction amplication. J. Clin. Endocrinol. Metab. 74, 1247-1252 (1992).
12. L. M. Forrester, J. D. Hayes, R. Millis, D. Barnes, A. L. Harris, J. J. Schlager, G. Powis, and C. R. Wolf: Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue. Carcinogenesis 11, 2163-2170 (1990).
13. G. I. Murray, R. J. Weaver, P. J. Paterson, S. W. B. Ewen, W. T. Melvin, and M. D. Burke: Expression of xenobiotic metabolizing enzymes in breast cancer. J. Pathol. 169, 347-353 (1993).
14. G. I. Murray, C. O. Foster, T. S. Barnes, R. J. Weaver, S. W. B. Ewen, W. T. Melvin, and M. D. Burke: Expression of cytochrome P450IA in breast cancer. Br. J. Cancer 63, 1021-1023 (1991).
15. G. Smith, D. J. Harrison, N. East, F. Rae, H. Wolf, and C. R. Wolf: Regulation of cytochrome P450 gene expression in human colon and breast tumour xenografts. Br. J. Cancer 68, 57-63 (1993).
16. T. I. Senler, W. L. Dean, L. F. Murray, and J. L. Wittliff: Quantification of cytochrome P-450-dependent cyclohexane hydroxylase activity in normal and neoplastic reproductive tissues. J. Biochem. 227, 379-387 (1985).
17. K. Pyykkö, R. Tuimala, L. Aalto, and T. Perkiö: Is aryl hydrocarbon hydroxylase activity a new prognostic indicator for breast cancer? Br. J. Cancer 63, 596-600 (1991).
18. A. R. Hoffman, S. M. Paul, and J. Axelrod: Catecholestrogen synthesis and metabolism by human breast tumors in vitro. Cancer Res. 39, 4584-4587 (1979).
19. Y. J. Abul-Hajj, J. H. H. Thijssen, and M. A. Blankenstein: Metabolism of estradiol by human breast cancer. Eur. J. Cancer Clin. Oncol. 24, 1171-1178 (1988).
20. R. Seshadri, N. D. Bagli-Vania, J. N. Suraiya, and N. A. Sheth: Conversion to estriol in "normal," benign and malignant human breast tissues. J. Cancer Res. Clin. Oncol. 116, 271-274 (1990).
21. H. Hellmond, M. Warner, E. Reihnér, and J.-Å. Gustafsson: Characterization of xenobiotic metabolizing cytochrome P450 enzymes in human and rat breast tissue. 10th International Symposium on Microsomes and Drug Oxidations. Toronto, Ontario, Canada, July 18-21, 1994.
22. M. Warner, M., H. Hellmond, E. Renier, and J.-A. Gustafsson: Cytochrome P450 in the breast: role in in situ activation of carcinogens and modulation by dietary components. In "Dietary Phytoestrogens: Cancer Cause or Prevention?" National Cancer Institute, Hendon, VA, September 21-23, 1994.
23. K. Keyomarsi and A. Pardee: Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 90, 1112-1116 (1993).
24. D. D. Dilworth and J. R. McCarrey: Single-step elimination of contaminating DNA prior to reverse transcriptase PCR. PCR Methods Applic. 1, 279-282 (1992).
25. Z. Huang, M. J. Fasco, and L. S. Kaminsky: Optimization of DNase I removal of contaminating DNA from RNA for use in quantitation RNA-PCR. Biotechniques, 20, 1012-1020 (1996).
26. D. R. Nelson, T. Kamataki, D. J. Waxman, F. P. Guengerich, R. W. Estabrook, R. Feyereisen, F. J. Gonzalez, M. J. Coon, I. C. Gunsalus, O. Gotoh, K. Okuda, and D. W. Nebert: The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 12, 1-51 (1993).
27. C. R. Ghosn, D. W. Gil, A. F. Spanoyannis, and M. E. Stern: Synthesis of selective nonradioactive probes by unidirectional PCR. Biochemica 11, 22-24 (1990).
28. F. J. Gonzalez, C. R. Skoda, S. Kimura, M. Umeno, U. M. Zanger, D. W. Nebert, H. V. Gelboin, J. P. Hardwick, and U. A. Meyer: Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 331, 442-446 (1988).
29. M. Christou, U. Savas, D. C. Spink, J. F. Gierthy, and C. R. Jefcoate: Co-expression of human CYP1A1 and a human analog of cytochrome P450-EF in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin in the human mammary carcinoma-derived MCF-7 cells. Carcinogenesis 15, 725-732 (1994).
30. F. P. Guengerich: Characterization of human cytochrome P450 enzymes. FASEB J. 6, 745-748 (1992).
31. D. C. Spink, C. L. Hayes, N. R. Young, M. Christou, T. R. Sutter, C. R. Jefcoate, and J. F. Gierthy: The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17β-estradiol 4-hydroxylase. J. Steroid Biochem. Mol. Biol. 51, 251-258 (1994).
32. J. G. Liehr: Genotoxic effects of estrogens. Mutat. Res. 238, 269-276 (1990).
33. K. Kawajiri, K. Nakachi, K. Imai, J. Watanabe, and S. Hayashi: The CYP1A1 gene and cancer susceptibility. Crit. Rev. Oncol. Hematol. 14, 77-87 (1993).
34. E. Taioli, J. Trachman, X. Chen, P. Toniolo, and S. J. Garte: A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res. 55, 3757-3758 (1995).
35. S. A. Wrighton and J. C. Stevens: The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol. 22, 1-21 (1992).
36. V. Kerlan, Y. Dreano, J. P. Bercovici, P. H. Beaune, H. H. Floch, and F. Berthou: Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes. Biochem. Pharmacol. 44, 1745-1756 (1992).
37. F. Jacolot, I. Simon, Y. Dreano, P. Beaune, C. Riche, and F. Berthou: Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes. Biochem. Pharmacol. 41, 1911-1919 (1991).
38. C. Mani, R. Pearce, A. Parkinson, and D. Kupfer: Involvement of cytochrome P4503A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes. Carcinogenesis 15, 2715-2720 (1994).